Goodwin Procter LLP advised Checkmate Pharmaceuticals, Inc., while Latham & Watkins LLP represents the underwriters in the offering. Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) closed its initial public…
Checkmate Pharmaceuticals, Inc.’s $75 Million IPO
